Cultured hypothalamic neurons are resistant to inflammation and insulin resistance induced by saturated fatty acids.
Hypothalamic inflammation induced by high-fat feeding causes insulin and leptin resistance and contributes to the pathogenesis of obesity. Since in vitro exposure to saturated fatty acids causes inflammation and insulin resistance in many cultured cell types, we determined how cultured hypothalamic neurons respond to this stimulus. Two murine hypothalamic neuronal cell cultures, N43/5 and GT1-7, were exposed to escalating concentrations of saturated fatty acids for up to 24 h. Harvested cells were evaluated for activation of inflammation by gene expression and protein content. Insulin-treated cells were evaluated for induction of markers of insulin receptor signaling (p-IRS, p-Akt). In both hypothalamic cell lines, inflammation was induced by prototypical inflammatory mediators LPS and TNFalpha, as judged by induction of IkappaBalpha (3- to 5-fold) and IL-6 (3- to 7-fold) mRNA and p-IkappaBalpha protein, and TNFalpha pretreatment reduced insulin-mediated p-Akt activation by 30% (P < 0.05). By comparison, neither mixed saturated fatty acid (100, 250, or 500 microM for <or=6 h) nor palmitate exposure alone (200 microM for <or=24 h) caused inflammatory activation or insulin resistance in cultured hypothalamic neurons, whereas they did in control muscle and endothelial cell lines. Despite the lack of evidence of inflammatory signaling, saturated fatty acid exposure in cultured hypothalamic neurons causes endoplasmic reticulum stress, induces mitogen-activated protein kinase, and causes apoptotic cell death with prolonged exposure. We conclude that saturated fatty acid exposure does not induce inflammatory signaling or insulin resistance in cultured hypothalamic neurons. Therefore, hypothalamic neuronal inflammation in the setting of DIO may involve an indirect mechanism mediated by saturated fatty acids on nonneuronal cells.
Choi
Sun Ju
SJ
Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine and Diabetes, University of Washington, Seattle, WA 98109-4714, USA.
Kim
Francis
F
Schwartz
Michael W
MW
Wisse
Brent E
BE
D000818:Animals; D015153:Blotting, Western; D002460:Cell Line; D004721:Endoplasmic Reticulum / Q000378:metabolism / Q000473:pathology; D005227:Fatty Acids / Q000008:administration & dosage*; D020869:Gene Expression Profiling / Q000379:methods; D007031:Hypothalamus / Q000378:metabolism* / Q000473:pathology; D051550:I-kappa B Kinase / Q000096:biosynthesis / Q000235:genetics; D007249:Inflammation / Q000378:metabolism / Q000473:pathology; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance / Q000276:immunology*; D015850:Interleukin-6 / Q000096:biosynthesis / Q000235:genetics; D051379:Mice; D009765:Obesity / Q000378:metabolism* / Q000473:pathology; D016133:Polymerase Chain Reaction; D051057:Proto-Oncogene Proteins c-akt / Q000096:biosynthesis / Q000235:genetics; D012333:RNA, Messenger / Q000737:chemistry / Q000235:genetics; D011972:Receptor, Insulin / Q000378:metabolism
D005227:Fatty Acids; D007328:Insulin; D015850:Interleukin-6; D012333:RNA, Messenger; D011972:Receptor, Insulin; D051057:Proto-Oncogene Proteins c-akt; D051550:I-kappa B Kinase